Study tracks new Drug's power to free patients from frequent blood transfusions
NCT ID NCT07215975
Summary
This study is observing how a drug called luspatercept works for adults with severe beta-thalassemia in the Middle East. The goal is to see if the drug can help patients need fewer blood transfusions and improve their hemoglobin levels. Researchers will follow 200 patients who are already taking the drug to collect real-world information on its effectiveness and safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Β-THALASSEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Prince Muhammad bin Nasser Hospital
NOT_YET_RECRUITINGJizan, Saudi Arabia
-
Sultan Qaboos University Hospital
RECRUITINGSeeb, Muḩāfaz̧at Masqaţ, 123, Oman
Contact
Conditions
Explore the condition pages connected to this study.